AngioDynamics to Report Fiscal Third Quarter 2009 Financial Results and Hold Conference Call on April 2, 2009QUEENSBURY, N.Y.--(BUSINESS WIRE)--Mar. 24, 2009--
AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of
innovative medical devices used by interventional radiologists,
nephrologists and surgeons for the minimally invasive treatment of
cancer and peripheral vascular disease, announced today that it will
report its fiscal third quarter financial results on
Thursday, April 2,
2009 after the close of the financial markets.
Jan Keltjens, president and chief executive officer, and Joseph Gersuk,
executive vice president and CFO, will host an investment community
conference call beginning at 4:30 p.m. Eastern time on April 2 to
discuss these results and to answer questions.
To participate in the live call by telephone, please dial (800) 257-7087
from the U.S., or for international callers, please dial +1 (303)
262-2140.
Those interested in listening to the conference call live via the
Internet may do so by visiting the Investor Relations section of
AngioDynamics’ website at http://investor.angiodynamics.com.
To listen to the live call, please go to the website 15 minutes prior to
its start to register, download, and install the necessary audio
software.
A replay will be available on the website. A telephone replay will be
available from 6:30 p.m. Eastern time on April 2, 2009 through 11:59
p.m. Eastern time on April 9 by dialing (800) 405-2236 (domestic) or +1
(303) 590-3000 (international) and entering the passcode: 11128472#.
About AngioDynamics
AngioDynamics, Inc. is a leading provider of innovative medical devices
used by interventional radiologists, nephrologists and surgeons for the
minimally invasive treatment of cancer and peripheral vascular disease.
The Company's diverse product line includes market-leading
radiofrequency ablation and irreversible electroporation ablation
systems, vascular access products, angiographic products and
accessories, dialysis products, angioplasty products, drainage products,
thrombolytic products, embolization products and venous products. More
information is available at www.angiodynamics.com.
Source: AngioDynamics, Inc.
AngioDynamics, Inc.
D. Joseph
Gersuk, CFO, 800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or
EVC
Group, Inc.
Investor Relations:
Doug Sherk,
415-896-6820
dsherk@evcgroup.com
Jenifer
Kirtland, 415-896-6820
jkirtland@evcgroup.com
Media:
Chris
Gale, 646-201-5431
cgale@evcgroup.com
